11月20日 - ** 癌症测试制造商Exact Sciences EXAS.O的股价盘前上涨17.6%，至101.38美元
** 医疗设备制造商雅培ABT.N称将以约210亿美元的价格收购EXAS，进军快速增长的癌症诊断领域
** 根据交易条款，ABT将以每股105美元的价格收购EXAS的所有流通股，比EXAS最后收盘价溢价21.8%。
** 交易预计在 2026 年第二季度完成
** 截至上一交易日收盘，EXAS上涨53.4%，ABT上涨11.5%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.